Cargando…
Progress and Challenges in Precise Treatment of Tumors With PD-1/PD-L1 Blockade
Immune checkpoint inhibitors target the inhibitory receptors on T cells to reinstate their antitumor ability and have shown significant efficacy in treating various cancers. However, because of tumor heterogeneity and many other uncover reasons, the objective response rate for programmed death 1 and...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080697/ https://www.ncbi.nlm.nih.gov/pubmed/32226426 http://dx.doi.org/10.3389/fimmu.2020.00339 |